Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cefditoren pivoxil.

Malcolm J M Darkes1, Greg L Plosker

  • 1Adis International Limited, Mairangi Bay, Auckland, New Zealand. demail@adis.co.nz

Drugs
|January 31, 2002
PubMed
Summary
This summary is machine-generated.

Cefditoren pivoxil is an effective oral antibiotic for respiratory and skin infections, demonstrating high cure rates against common pathogens. It shows good tolerability, with diarrhea and nausea as the most frequent side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Cladribine Tablets: In Relapsing-Remitting Multiple Sclerosis.

CNS drugs·2020
Same author

Asenapine: A Review in Schizophrenia.

CNS drugs·2016
Same author

Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study.

Neurology and therapy·2015
Same author

AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus.

Drugs·2015
Same author

13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults.

Drugs·2015
Same author

Acamprosate: A Review of Its Use in Alcohol Dependence.

Drugs·2015
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
Same journal

Linerixibat: First Approval.

Drugs·2026
See all related articles

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Bacteriology

Background:

  • Cefditoren pivoxil is an oral prodrug of cefditoren, a third-generation cephalosporin.
  • Cefditoren exhibits broad-spectrum activity against Gram-positive and Gram-negative bacteria.

Purpose of the Study:

  • To evaluate the efficacy and safety of cefditoren pivoxil in treating acute exacerbations of chronic bronchitis (AECB), streptococcal pharyngitis, and skin infections.
  • To compare cefditoren pivoxil with other commonly used antibiotics.

Main Methods:

  • Randomized, double-blind clinical trials were conducted in patients with AECB, streptococcal pharyngitis, and skin infections.
  • Patients received cefditoren pivoxil at various dosages (200-400mg twice daily) for 10 days.
  • Clinical cure rates and adverse events were assessed and compared to control groups.

Related Experiment Videos

Main Results:

  • Cefditoren pivoxil achieved high clinical cure rates (88-94%) in patients with AECB, streptococcal pharyngitis, and skin infections.
  • Efficacy was comparable to clarithromycin, cefuroxime axetil, cefadroxil, and phenoxymethylpenicillin potassium.
  • Common adverse events included diarrhea, nausea, headache, abdominal pain, and vaginal candidiasis.

Conclusions:

  • Cefditoren pivoxil is an effective oral antibiotic for treating common respiratory and skin infections.
  • It offers a favorable efficacy profile comparable to established antibiotics.
  • The drug is generally well-tolerated, with a manageable side effect profile.